{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:51:56Z","timestamp":1792734716477,"version":"4.5.0"},"reference-count":43,"publisher":"Ubiquity Press, Ltd.","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TOHM"],"abstract":"<jats:p>Background: Transcutaneous afferent patterned stimulation (TAPS) is a wrist-worn, non-invasive therapy delivering calibrated stimulation to the median and radial nerves. While the efficacy and safety of TAPS therapy for essential tremor (ET) have been demonstrated, current evidence supporting therapeutic benefits of TAPS versus standard of care (SOC) is lacking. This prospective study evaluated the clinical benefit of adding TAPS treatment to SOC versus SOC alone.\r\nMethods: This randomized, controlled, pragmatic trial recruited patients from a large health plan\u2019s Commercially Insured and Medicare Advantage population. 310 patients were randomized 1:1 to one month of treatment with TAPS (TX) or standard of care (SOC). The pre-specified endpoints were changes in tremor power measured by motion sensors (primary) and improvement in Bain &amp; Findley Activities of Daily Living (BF-ADL) upper limb scores reported (secondary) between TX and SOC at one month.\r\nResults: 276 patients completed the one-month endpoints (n=133 TX, n=143 SOC). The study met the primary and secondary endpoints, with significantly reduced tremor power in TX than SOC (0.017 (0.003) versus 0.08 (0.014) (m\/s2)2; geometric mean (SE); p &lt; 0.0001) and greater improvement in the BF-ADL score in TX than SOC (1.6 (0.43) vs 0.2 (0.37) points; mean (SE); p &lt; 0.05). 82% of TX patients experienced tremor improvement from before to after therapy. No serious device-related adverse events were reported.\r\nDiscussion: This trial demonstrates that TAPS significantly improves tremor power and BF-ADLs in patients with ET compared to SOC over one month of home use.\r\nHighlights\r\nThis study found that TAPS significantly improves tremor power and BF-ADL scores in patients with ET compared to SOC over one month of home use. This real-world study suggests that non-invasive TAPS therapy is a safe and valuable treatment option for patients with ET.<\/jats:p>","DOI":"10.5334\/tohm.798","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T12:46:32Z","timestamp":1697460392000},"page":"38","source":"Crossref","is-referenced-by-count":17,"title":["Comparative Effectiveness of Transcutaneous Afferent Patterned Stimulation Therapy for Essential Tremor: A Randomized Pragmatic Clinical Trial"],"prefix":"10.5334","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9385-0992","authenticated-orcid":false,"given":"Dingwei","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6037-8588","authenticated-orcid":false,"given":"Joaquim","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5929-8444","authenticated-orcid":false,"given":"Han","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Coetzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"issue":"3","key":"key20231016084627_B1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12311-009-0111-y","article-title":"Balance and motor speech impairment in essential tremor","volume":"8","year":"2009","journal-title":"Cerebellum"},{"issue":"8","key":"key20231016084627_B2","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJMe1606517","article-title":"Treatment of medically refractory essential tremor","volume":"375","year":"2016","journal-title":"N Engl J Med"},{"key":"key20231016084627_B3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fneur.2017.00396","article-title":"The experience of essential tremor caregivers: burden and its correlates","volume":"8","year":"2017","journal-title":"Front Neurol"},{"issue":"10","key":"key20231016084627_B4","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.apmr.2014.04.001","article-title":"Balance confidence and falls in nondemented essential tremor patients: the role of cognition","volume":"95","year":"2014","journal-title":"Arch Phys Med Rehabil"},{"key":"key20231016084627_B5","doi-asserted-by":"crossref","first-page":"04028","DOI":"10.7189\/jogh.11.04028","article-title":"The global prevalence of essential tremor, with emphasis on age and sex: A meta-analysis","volume":"11","year":"2021","journal-title":"J Glob Health"},{"key":"key20231016084627_B6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5334\/tohm.198","article-title":"How many people in the USA have essential tremor? Deriving a population estimate based on epidemiological data","volume":"4","year":"2014","journal-title":"Tremor Hyperkinetic Mov"},{"issue":"2","key":"key20231016084627_B7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.36469\/jheor.2022.37307","article-title":"Multiple comorbidities, psychiatric disorders, healthcare resource utilization and costs among adults with essential tremor: a retrospective observational study in a large US commercially insured and Medicare Advantage population","volume":"9","year":"2022","journal-title":"J Health Econ Outcomes Res"},{"issue":"12","key":"key20231016084627_B8","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1007\/s12325-022-02318-8","article-title":"The hidden burden of disease and treatment experiences of patients with essential tremor: a retrospective claims data analysis","volume":"39","year":"2022","journal-title":"Adv Ther"},{"issue":"962","key":"key20231016084627_B9","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/pgmj.2005.032979","article-title":"Differential diagnosis of common tremor syndromes","volume":"81","year":"2005","journal-title":"Postgrad Med J"},{"key":"key20231016084627_B10","first-page":"100101","article-title":"Exploring essential tremor: Results from a large online survey","volume":"5","year":"2021","journal-title":"Clin Park Relat Disord"},{"key":"key20231016084627_B11","first-page":"91","article-title":"Treatment of Essential Tremor: Are there Issues We are Overlooking?","volume":"2","year":"2012","journal-title":"Front Neurol"},{"issue":"7","key":"key20231016084627_B12","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/mds.27700","article-title":"MDS evidence-based review of treatments for essential tremor","volume":"34","year":"2019","journal-title":"Mov Disord"},{"key":"key20231016084627_B13","doi-asserted-by":"crossref","first-page":"819730","DOI":"10.3389\/fnagi.2022.819730","article-title":"Complications after deep brain stimulation: a 21-year experience in 426 patients","volume":"14","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"key20231016084627_B14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/mds.26997","article-title":"Cost-effectiveness of focused ultrasound, radiosurgery, and DBS for essential tremor","volume":"32","year":"2017","journal-title":"Mov Disord"},{"issue":"8","key":"key20231016084627_B15","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.27372","article-title":"International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson\u2019s disease","volume":"33","year":"2018","journal-title":"Mov Disord"},{"key":"key20231016084627_B16","unstructured":"Lyons KE, OTT KR, Shill H. Essential Tremor Guidelines Advisory \u2013 Essential Tremor Advisory \u2013 IETF [Internet]. [cited 2023 Jun 30]. Available from: https:\/\/eguideline.guidelinecentral.com\/i\/1380755-essential-tremor-advisory-ietf\/0?."},{"key":"key20231016084627_B17","unstructured":"U.S. Food & Drug Administration. 510(k) Premarket Notification for Cala Trio (K203288) [Internet]. 2021 [cited 2023 Jun 30]. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K203288."},{"key":"key20231016084627_B18","unstructured":"U.S. Food & Drug Administration. De Novo Classification Request for Cala ONE (DEN170027) [Internet]. 2017 [cited 2023 Jun 30]. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K203288."},{"issue":"5","key":"key20231016084627_B19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/ner.12930","article-title":"An acute randomized controlled trial of noninvasive peripheral nerve stimulation in essential tremor","volume":"22","year":"2019","journal-title":"Neuromodulation"},{"key":"key20231016084627_B20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5334\/tohm.59","article-title":"Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor","volume":"10","year":"2020","journal-title":"Tremor Hyperkinetic Mov"},{"key":"key20231016084627_B21","doi-asserted-by":"crossref","first-page":"530300","DOI":"10.3389\/fnins.2020.530300","article-title":"Transcutaneous Afferent Patterned Stimulation Therapy Reduces Hand Tremor for One Hour in Essential Tremor Patients","volume":"14","year":"2020","journal-title":"Front Neurosci"},{"issue":"1","key":"key20231016084627_B22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5334\/tohm.715","article-title":"Real-World Evidence of Transcutaneous Afferent Patterned Stimulation for Essential Tremor","volume":"12","year":"2022","journal-title":"Tremor Hyperkinetic Mov"},{"issue":"7","key":"key20231016084627_B23","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/mds.27350","article-title":"Noninvasive neuromodulation in essential tremor demonstrates relief in a sham-controlled pilot trial: Neuromodulation for Essential Tremor","volume":"33","year":"2018","journal-title":"Mov Disord"},{"key":"key20231016084627_B24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5334\/tohm.685","article-title":"Rationale and Evidence for Peripheral Nerve Stimulation for Treating Essential Tremor","volume":"12","year":"2022","journal-title":"Tremor Hyperkinetic Mov"},{"issue":"2","key":"key20231016084627_B25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0976-500X.72352","article-title":"CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials","volume":"1","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"key":"key20231016084627_B26","first-page":"26335565221098830","article-title":"Multiple comorbid conditions and healthcare resource utilization among adult patients with hyperkalemia: A retrospective observational cohort study using association rule mining","volume":"12","year":"2022","journal-title":"J Multimorb Comorbidity"},{"issue":"12","key":"key20231016084627_B27","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jclinepi.2008.01.006","article-title":"The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients","volume":"61","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"key20231016084627_B28","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/jnnp.56.8.868","article-title":"Assessing tremor severity","volume":"56","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"key20231016084627_B29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.parkreldis.2013.09.009","article-title":"Continuous in-home monitoring of essential tremor","volume":"20","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"key20231016084627_B30","first-page":"96","article-title":"Continuous Monitoring of Essential Tremor Using a Portable System Based on Smartwatch","volume":"8","year":"2017","journal-title":"Front Neurol"},{"issue":"2","key":"key20231016084627_B31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1212\/WNL.36.2.225","article-title":"Physiologic and essential tremor","volume":"36","year":"1986","journal-title":"Neurology"},{"issue":"7","key":"key20231016084627_B32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.parkreldis.2011.04.017","article-title":"Essential tremor quantification during activities of daily living","volume":"17","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"key20231016084627_B33","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/mdc3.13558","article-title":"Continuous Monitoring of Essential Tremor: Standards and Challenges","volume":"9","year":"2022","journal-title":"Movement Disord Clin Pract"},{"issue":"1","key":"key20231016084627_B34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5334\/tohm.775","article-title":"Transcutaneous Afferent Patterned Stimulation for Essential Tremor: Real-World Evidence with Long Term Follow-Up","volume":"13","year":"2023","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"key20231016084627_B35","doi-asserted-by":"crossref","first-page":"120195","DOI":"10.1016\/j.jns.2022.120195","article-title":"Non-invasive electrical stimulation of peripheral nerves for the management of tremor","volume":"435","year":"2022","journal-title":"J Neurol Sci"},{"issue":"4","key":"key20231016084627_B36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.cpr.2013.02.002","article-title":"Researcher allegiance in psychotherapy outcome research: an overview of reviews","volume":"33","year":"2013","journal-title":"Clin Psychol Rev"},{"issue":"13","key":"key20231016084627_B37","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/(SICI)1097-0258(19960715)15:13<1421::AID-SIM266>3.0.CO;2-H","article-title":"An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation\u2014a VA cooperative study","volume":"15","year":"1996","journal-title":"Stat Med"},{"key":"key20231016084627_B38","first-page":"401","article-title":"Overview of essential tremor","volume":"6","year":"2010","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"key20231016084627_B39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1474-4422(10)70322-7","article-title":"Treatment of patients with essential tremor","volume":"10","year":"2011","journal-title":"Lancet Neurol"},{"issue":"1132","key":"key20231016084627_B40","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/postgradmedj-2019-136647","article-title":"Treatment of essential tremor: current status","volume":"96","year":"2020","journal-title":"Postgrad Med J"},{"issue":"2","key":"key20231016084627_B41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ncl.2020.01.002","article-title":"Current and Emerging Treatments of Essential Tremor","volume":"38","year":"2020","journal-title":"Neurol Clin"},{"issue":"7","key":"key20231016084627_B42","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1111\/ejn.12307","article-title":"Challenges of proper placebo control for non-invasive brain stimulation in clinical and experimental applications","volume":"38","year":"2013","journal-title":"Eur J Neurosci"},{"key":"key20231016084627_B43","first-page":"29","article-title":"Medical Treatment of Essential Tremor","volume":"6","year":"2014","journal-title":"J Cent Nerv Syst Dis"}],"container-title":["Tremor and Other Hyperkinetic Movements"],"original-title":[],"link":[{"URL":"https:\/\/account.tremorjournal.org\/index.php\/up-j-tohm\/article\/download\/798\/1766","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/account.tremorjournal.org\/index.php\/up-j-tohm\/article\/download\/798\/1767","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/account.tremorjournal.org\/index.php\/up-j-tohm\/article\/download\/798\/1768","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/account.tremorjournal.org\/index.php\/up-j-tohm\/article\/download\/798\/1766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T12:52:47Z","timestamp":1697460767000},"score":1,"resource":{"primary":{"URL":"https:\/\/account.tremorjournal.org\/index.php\/up-j-tohm\/article\/view\/798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":43,"URL":"https:\/\/doi.org\/10.5334\/tohm.798","relation":{},"ISSN":["2160-8288"],"issn-type":[{"value":"2160-8288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]}}}